These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6741437)

  • 21. [Importance of selected laboratory indicators in the differential diagnosis and monitoring of multiple myeloma].
    Maisnar V; Tousková M; Malý J; Krejsek J; Kmonícek M; Kopecký O
    Vnitr Lek; 2002 Apr; 48(4):290-7. PubMed ID: 12061177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis of malignant gammopathies].
    Emmerich B
    Dtsch Med Wochenschr; 1984 Jan; 109(1):24-6. PubMed ID: 6420137
    [No Abstract]   [Full Text] [Related]  

  • 23. [Monoclonal gammopathies. Progress in differential diagnosis based on immunologic markers].
    Caballero MD; González M; San Miguel J
    Sangre (Barc); 1984; 29(5):913-7. PubMed ID: 6441294
    [No Abstract]   [Full Text] [Related]  

  • 24. [Contribution of bone biopsy with histomorphometry in the evaluation of monoclonal gammopathy].
    Alexandre C; Bataille R; Chappard D; Dessauw P; Sany J; Riffat G
    Rev Rhum Mal Osteoartic; 1987 Nov; 54(11):717-21. PubMed ID: 3423714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow T-cell subsets in patients with monoclonal gammopathies: correlation with clinical stage and disease status.
    Corso A; Castelli G; Pagnucco G; Lazzarino M; Bellio L; Klersy C; Bernasconi C
    Haematologica; 1997; 82(1):43-6. PubMed ID: 9107081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal gammopathies and aging.
    Cohen HJ
    Hosp Pract (Off Ed); 1988 Mar; 23(3A):75-80, 82, 85-9 passim. PubMed ID: 3127410
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
    Ocqueteau M; Orfao A; Almeida J; Bladé J; González M; García-Sanz R; López-Berges C; Moro MJ; Hernández J; Escribano L; Caballero D; Rozman M; San Miguel JF
    Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Benign and malignant plasma cell dyscrasias: methods of study].
    Geniram A; Fiorini G; Spotti D; Frezzini G; Guarino P; Venturino M; Marini U
    Haematologica; 1984; 69(2):163-77. PubMed ID: 6203816
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative cytochemical study of some enzymatic activities in normal and myelomatous plasma cells (author's transl)].
    Invernizzi R; Ippoliti G; Cattaneo G; Trpin L; Casirola G; Carnevale-Maffé G; Cordani M
    Haematologica; 1979 Dec; 64(6):726-34. PubMed ID: 161879
    [No Abstract]   [Full Text] [Related]  

  • 30. Should bone marrow examination be routinely performed for the diagnosis of monoclonal gammopathy of undetermined significance?
    Elis A; Radnay J; Shapiro H; Itzhaky D; Manor Y; Lishner M
    Isr Med Assoc J; 2006 Dec; 8(12):840-2. PubMed ID: 17214099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes.
    Girlanda S; Fortis C; Belloni D; Ferrero E; Ticozzi P; Sciorati C; Tresoldi M; Vicari A; Spies T; Groh V; Caligaris-Cappio F; Ferrarini M
    Cancer Res; 2005 Aug; 65(16):7502-8. PubMed ID: 16103105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma cell acid phosphatase score in multiple myeloma and related disorders.
    Hoffmann JJ; Breed WP; Swaak-Lammers N
    Br J Haematol; 1985 Jan; 59(1):67-72. PubMed ID: 3970852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Monoclonal gammopathies of undetermined significance].
    Hofmann V
    Schweiz Med Wochenschr; 1982 Nov; 112(48):1718-23. PubMed ID: 6817412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benign and malignant monoclonal gammopathies.
    Carney DN; Bunn PA
    Prim Care; 1980 Sep; 7(3):369-94. PubMed ID: 6777792
    [No Abstract]   [Full Text] [Related]  

  • 35. An approach to monoclonal gammopathies in the elderly.
    Crawford J; Cohen HJ
    Geriatrics; 1982 Oct; 37(10):97-100, 105-6, 111-2. PubMed ID: 7117845
    [No Abstract]   [Full Text] [Related]  

  • 36. The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells.
    Ng AP; Wei A; Bhurani D; Chapple P; Feleppa F; Juneja S
    Haematologica; 2006 Jul; 91(7):972-5. PubMed ID: 16818287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
    Martín P; Santón A; Bellas C
    Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
    Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
    Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conventional diagnostics in multiple myeloma.
    San Miguel JF; Gutiérrez NC; Mateo G; Orfao A
    Eur J Cancer; 2006 Jul; 42(11):1510-9. PubMed ID: 16762540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation between benign and malignant monoclonal gammopathies by discriminant analysis on serum and bone marrow parameters.
    Morell A; Maurer W; Skvaril F; Barandun S
    Acta Haematol; 1978; 60(3):129-36. PubMed ID: 101000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.